首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >Chinese Medicine Formula Lingguizhugan Decoction Improves Beta-Oxidation and Metabolism of Fatty Acid in High-Fat-Diet-Induced Rat Model of Fatty Liver Disease
【2h】

Chinese Medicine Formula Lingguizhugan Decoction Improves Beta-Oxidation and Metabolism of Fatty Acid in High-Fat-Diet-Induced Rat Model of Fatty Liver Disease

机译:中药配方灵桂竹肝汤改善高脂饮食诱导的脂肪肝大鼠模型中β-氧化和脂肪酸代谢

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lingguizhugan decoction (LGZG), a classic traditional Chinese medicine (TCM) formula, has been used to treat obesity and hyperlipidemia in recent years, but the related mechanisms underlying the regulation of lipid metabolism by LGZG are not clear yet. Here, we reported the effectiveness and possible mechanisms of LGZG on rats with fatty liver disease induced by high-fat diet (HFD). Our results demonstrated that LGZG significantly attenuated HFD-induced fatty liver disease, as measured by body weight, liver index, epididymal fat pad-body weight ratio (EFP/BW), liver injury, and hepatic triglycerides (TG) probably through increasing serum thyroid hormone levels, improving beta-oxidation (via modulation of TRβ1 and CPT1A expression), metabolism and transport (through modulation of SREBP-1c, ACSL and ApoB100 expression) of fatty acid. In addition, we discovered the herbal combination with the properties of warming yang to relieve water retention in the formula and proposed the biological basis of LGZG conventional effect via further study on disassembled formula. This study, for the first time, revealed the mechanisms through which LGZG regulates lipid metabolism. Furthermore, our study suggested that it might be feasible to understand the scientific implications of TCM from the perspective of classic formulas' conventional efficacy.
机译:近年来,经典的中药(TCM)配方-灵桂竹肝汤(LGZG)已被用于治疗肥胖和高血脂症,但LGZG调节脂质代谢的相关机制尚不清楚。在这里,我们报道了LGZG对高脂饮食(HFD)诱发的脂肪性肝病大鼠的有效性和可能的​​机制。我们的结果表明,通过体重,肝指数,附睾脂肪垫体重比(EFP / BW),肝损伤和肝甘油三酸酯(TG)的测量,LGZG可以显着减轻HFD诱发的脂肪肝疾病激素水平,改善脂肪酸的β-氧化(通过调节TRβ1和CPT1A表达),代谢和运输(通过调节SREBP-1c,ACSL和ApoB100表达)。此外,我们在配方中发现了具有温阳性的草药组合,以减轻水分滞留,并通过对分解配方的进一步研究,提出了LGZG常规作用的生物学基础。这项研究首次揭示了LGZG调节脂质代谢的机制。此外,我们的研究表明,从经典配方的常规功效角度了解中药的科学含义可能是可行的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号